Skip to main content
. Author manuscript; available in PMC: 2010 Feb 10.
Published in final edited form as: Biometrics. 2008 May 13;65(1):307. doi: 10.1111/j.1541-0420.2008.01045.x

Table 1.

Example of a trial with continuous outcomes with subjects assigned in cohorts of three. The target AGT activity is 5 fmol/mg protein. Data were resampled from Friedman et al. (1998). The new design with Δ = 1 is used.

Ȳj t-statistic Decision
Dose 1, 40 mg/m2
(y11, y12, y13) = (26.35, 42.00, 15.00) 27.78 2.91 Increase the dose to 60 mg/m2
Dose 2, 60 mg/m2
(y21, y22, y23) = (23.00, 13.50, 10.83) 15.78 2.92 Increase the dose to 80 mg/m2
Dose 3, 80 mg/m2
(y31, y32, y33) = (11.70, 9.03, 5.00) 8.58 1.84 Increase the dose to 100 mg/m2
Dose 4, 100 mg/m2
(y41, y42, y43) = (4.07, 5.00, 8.70) 5.92 0.65 Repeat the dose at 100 mg/m2
(y44, y45, y46) = (2.50, 4.07, 6.13) 5.08a 0.09a Repeat the dose at 100 mg/m2
(y47, y48, y49) = (3.60, 5.00, 5.00) 4.90a −0.18a Repeat the dose at 100 mg/m2
(y410, y411) = (6.80, 6.60) 5.22a 0.43a Repeat the dose at 100 mg/m2
a

Calculated based on the combined sample.